# Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions

> **NCT01305356** · NA · COMPLETED · sponsor: **BioMimetic Therapeutics** · enrollment: 299 (actual)

## Conditions studied

- Degenerative Joint Disease
- Congenital Deformity
- Arthritis
- Osteoarthritis
- Rheumatoid Arthritis

## Interventions

- **DEVICE:** Augment® Injectable Bone Graft
- **PROCEDURE:** Autologous bone graft

## Key facts

- **NCT ID:** NCT01305356
- **Lead sponsor:** BioMimetic Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2013-04
- **Final completion:** 2014-04
- **Target enrollment:** 299 (ACTUAL)
- **Last updated:** 2018-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01305356

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01305356, "Augment® Injectable Bone Graft Compared to Autologous Bone Graft as a Bone Regeneration Device in Hindfoot Fusions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01305356. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*